OUTLOOK 2021
Annual industry ranking and forecast
Value Of Digital
2020 showcased the real potential of virtual and digital tools as their use accelerated. Continued growth depends in part on attention to issues such as security and data privacy.
Locked And Bolted: How To Create A Data Fortress
Considering the increasing number of biopharmaceutical companies pursuing more virtual and digital tools, the need for world class digital protection is a pressing challenge. In Vivo talks to two cyber security experts about best practice when securing data assets.
The Golden Winged Warbler And Creating Pharma Supply Chain Immunity
Supply chain expert outlines to In Vivo how pharma can create resilient and secure supply chains and some benefits of localization.
COVID-19 Pandemic Accelerates Shift Toward Virtual Trials
As the global shut-down caused by the coronavirus pandemic continues, sponsors are rushing to adapt clinical trials that can move to partial or completely remote monitoring, allowing patients to remain in their homes but continue to participate in studies. And the outbreak may have another silver lining for the biopharma industry, a chance to rebuild its reputation.
Femtech Presents Enticing Market Opportunity
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
Chapter sponsored by:
Finding Common Ground: Bringing Together Perspectives On Connected Drug Delivery Devices
Health services around the world were already under pressure before the COVID pandemic, due to aging populations and the growth in chronic diseases.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.